Related references
Note: Only part of the references are listed.Meta-Analysis and Systematic Review to Assess the Role of Soluble FMS-Like Tyrosine Kinase-1 and Placenta Growth Factor Ratio in Prediction of Preeclampsia: The SaPPPhirE Study
Swati Agrawal et al.
HYPERTENSION (2018)
Pre-eclampsia and heart failure: a close relationship
R. Orabona et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Ultrasound evaluation of left ventricular and aortic fibrosis after pre-eclampsia
R. Orabona et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Novel anti-MBG antibodies protect cytotrophoblast cells from a marinobufagenin-induced preeclampsia phenotype
Mohammad N. Uddin et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2018)
Fibrosis in Preeclamptic Placentas Is Associated with Stromal Fibroblasts Activated by the Transforming Growth Factor-β1 Signaling Pathway
Takako Ohmaru-Nakanishi et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Antibody to Marinobufagenin Reverses Placenta-Induced Fibrosis of Umbilical Arteries in Preeclampsia
Olga V. Fedorova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Marinobufagenin in Urine: A Potential Marker of Predisposition to Ethanol and a Target for Spironolactone
Vladimir A. Kashkin et al.
CURRENT HYPERTENSION REVIEWS (2018)
Endothelial dysfunction and vascular stiffness in women with previous pregnancy complicated by early or late pre-eclampsia
R. Orabona et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2017)
Exposure to Experimental Preeclampsia in Mice Enhances the Vascular Response to Future Injury
Dafina Pruthi et al.
HYPERTENSION (2015)
Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists
Olga V. Fedorova et al.
JOURNAL OF HYPERTENSION (2015)
Angiotensin II Type 1 Receptor Autoantibody (AT1-AA)-Mediated Pregnancy Hypertension
Florian Herse et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
From placenta to podocyte: vascular and podocyte pathophysiology in preeclampsia
Steven J. Wagner et al.
CLINICAL NEPHROLOGY (2012)
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Vera Regitz-Zagrosek et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2012)
The association between preeclampsia and arterial stiffness
Anai S. Hausvater et al.
JOURNAL OF HYPERTENSION (2012)
DigiFab Interacts With Endogenous Cardiotonic Steroids and Reverses Preeclampsia-Induced Na/K-ATPase Inhibition
Valentina V. Ishkaraeva-Yakovleva et al.
REPRODUCTIVE SCIENCES (2012)
In preeclampsia endogenous cardiotonic steroids induce vascular fibrosis and impair relaxation of umbilical arteries
Elena R. Nikitina et al.
JOURNAL OF HYPERTENSION (2011)
EPLERENONE FOR GITELMAN SYNDROME IN PREGNANCY
Adam Morton et al.
NEPHROLOGY (2011)
ESC Guidelines on the management of cardiovascular diseases during pregnancy The Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC)
Vera Regitz-Zagrosek et al.
EUROPEAN HEART JOURNAL (2011)
The Treatment of Preeclampsia in a Rat Model Employing Digibind®
Enoch Agunanne et al.
AMERICAN JOURNAL OF PERINATOLOGY (2010)
Digoxin Immune Fab Treatment for Severe Preeclampsia
C. David Adair et al.
AMERICAN JOURNAL OF PERINATOLOGY (2010)
Maternal arterial stiffness in pregnancies affected by preeclampsia
Christina Kaihura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Estimation of proteinuria as a predictor of complications of pre-eclampsia: a systematic review
Shakila Thangaratinam et al.
BMC MEDICINE (2009)
Spironolactone Attenuates Experimental Uremic Cardiomyopathy by Antagonizing Marinobufagenin
Jiang Tian et al.
HYPERTENSION (2009)
Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic Targets
A. Y. Bagrov et al.
PHARMACOLOGICAL REVIEWS (2009)
Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy
Jihad Elkareh et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2009)
Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension
Olga V. Fedorova et al.
JOURNAL OF HYPERTENSION (2008)
Endogenous digitalis: pathophysiologic roles and therapeutic applications
Alexei Y. Bagrov et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2008)
Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis
Leanne Bellamy et al.
BMJ-BRITISH MEDICAL JOURNAL (2007)
Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy
Jihad Elkareh et al.
HYPERTENSION (2007)
Arterial stiffness in preeclamptic and chronic hypertensive pregnancies
Kati M. H. Tihtonen et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2006)
Brain ouabain stimulates peripheral marinobufagenin via angiotensin II signalling in NaCl-loaded Dahl-S rats
OV Fedorova et al.
JOURNAL OF HYPERTENSION (2005)
Antibody to marinobufagenin lowers blood pressure in pregnant rats on a high NaCl intake
OV Fedorova et al.
JOURNAL OF HYPERTENSION (2005)
Effect of canrenone on the digitalis site of Na+/K+-ATPase in human placental membranes and in erythrocytes
S Balzan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2003)
Arterial and cardiac aging: Major shareholders in cardiovascular disease enterprises Part I: Aging arteries: A set up for vascular disease
EG Lakatta et al.
CIRCULATION (2003)
Effects of uremic serum on isolated cardiac myocyte calcium cycling and contractile function
SM Periyasamy et al.
KIDNEY INTERNATIONAL (2001)
Share Paper
